Syncope and Cannabis: hypervagotonia from chronic abuse? A case report and literature review.
Asystole
Cannabis
Cardiac pace-maker
Cardiovascular effects
ILR implantation
Recurrent Syncope
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
25 10 2023
25 10 2023
Historique:
received:
12
04
2023
accepted:
17
10
2023
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
Cannabis is the most consumed drug worldwide and number of users is increasing, particularly among youth. Moreover, cannabis potential therapeutic properties have renewed interest to make it available as a treatment for a variety of conditions. Albeit rarely, cannabis consumption has been associated with cardiovascular diseases such as arrhythmias, myocardial infarction (MI) and potentially sudden death. A 24-year-old woman presented to the emergency department sent by her cardiologist because of a recent finding of a 16 seconds asystole on the implantable loop recorder (ILR) she implanted 7 months before for recurrent syncopes. She declared that she is a heavy cannabis user (at least 5 cannabis-cigarette per day, not mixed up with tobacco, for no less than 12 years) and all syncopes occurred shortly after cannabis consumption. After a collective discussion with the heart team, syncope unit, electrophysiologists and toxicologist, we decided to implant a dual chamber pacemaker with a rate response algorithm due to the high risk of trauma of the syncopal episodes. 24 months follow-up period was uneventful. Cannabis cardiovascular effects are not well known and, although rare, among these we find ischemic episodes, tachyarrhythmias, symptomatic sinus bradycardia, sinus arrest, ventricular asystole and possibly death. Because of cannabis growing consumption both for medical and recreational purpose, cardiovascular diseases associated with cannabis use may become more and more frequent. In the light of the poor literature, we believe that cannabis may produce opposite adverse effects depending on the duration of the habit. Acute administration increases sympathetic tone and reduces parasympathetic tone; conversely, with chronic intake an opposite effect is observed: repetitive dosing decreases sympathetic activity and increases parasympathetic activity. Clinicians should be aware of the increased risk of cardiovascular complications associated with cannabis use and should investigate its consumption especially in young patients presenting with cardiac dysrhythmias.
Sections du résumé
BACKGROUND
Cannabis is the most consumed drug worldwide and number of users is increasing, particularly among youth. Moreover, cannabis potential therapeutic properties have renewed interest to make it available as a treatment for a variety of conditions. Albeit rarely, cannabis consumption has been associated with cardiovascular diseases such as arrhythmias, myocardial infarction (MI) and potentially sudden death.
CASE PRESENTATION
A 24-year-old woman presented to the emergency department sent by her cardiologist because of a recent finding of a 16 seconds asystole on the implantable loop recorder (ILR) she implanted 7 months before for recurrent syncopes. She declared that she is a heavy cannabis user (at least 5 cannabis-cigarette per day, not mixed up with tobacco, for no less than 12 years) and all syncopes occurred shortly after cannabis consumption. After a collective discussion with the heart team, syncope unit, electrophysiologists and toxicologist, we decided to implant a dual chamber pacemaker with a rate response algorithm due to the high risk of trauma of the syncopal episodes. 24 months follow-up period was uneventful.
CONCLUSIONS
Cannabis cardiovascular effects are not well known and, although rare, among these we find ischemic episodes, tachyarrhythmias, symptomatic sinus bradycardia, sinus arrest, ventricular asystole and possibly death. Because of cannabis growing consumption both for medical and recreational purpose, cardiovascular diseases associated with cannabis use may become more and more frequent. In the light of the poor literature, we believe that cannabis may produce opposite adverse effects depending on the duration of the habit. Acute administration increases sympathetic tone and reduces parasympathetic tone; conversely, with chronic intake an opposite effect is observed: repetitive dosing decreases sympathetic activity and increases parasympathetic activity. Clinicians should be aware of the increased risk of cardiovascular complications associated with cannabis use and should investigate its consumption especially in young patients presenting with cardiac dysrhythmias.
Identifiants
pubmed: 37875800
doi: 10.1186/s12872-023-03566-4
pii: 10.1186/s12872-023-03566-4
pmc: PMC10598970
doi:
Types de publication
Review
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
518Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Cardiovasc Pathol. 2008 Sep-Oct;17(5):344-6
pubmed: 18402793
Clin Toxicol (Phila). 2020 Sep;58(9):861-869
pubmed: 32267189
Ther Drug Monit. 2013 Aug;35(4):493-501
pubmed: 23851906
J Electrocardiol. 2016 Jan-Feb;49(1):15-7
pubmed: 26520167
Am Heart J. 1977 Dec;94(6):740-7
pubmed: 920582
South Med J. 1981 Mar;74(3):371-3
pubmed: 6261403
Br J Pharmacol. 2006 Jan;147 Suppl 1:S163-71
pubmed: 16402100
Circulation. 2020 Sep 8;142(10):e131-e152
pubmed: 32752884
J Clin Pharmacol. 2002 Nov;42(S1):58S-63S
pubmed: 12412837
Adv Exp Med Biol. 2021;1264:67-80
pubmed: 33332004
Neurobiol Dis. 2013 Nov;59:141-50
pubmed: 23851307
Am J Med Sci. 2018 Jan;355(1):3-5
pubmed: 29289259
Drugs. 2019 Sep;79(13):1435-1454
pubmed: 31372958
Eur Heart J. 2018 Jun 1;39(21):1883-1948
pubmed: 29562304
J Am Soc Echocardiogr. 2010 May;23(5):516-22
pubmed: 20381311
Clin Pract Epidemiol Ment Health. 2018 Feb 27;14:26-32
pubmed: 29541148
J Clin Pharmacol. 1981 Aug-Sep;21(S1):214S-223S
pubmed: 6271827